Company: CERO
Filing Date: 2025-10-30
Form Type: 8-K
Source: 0001213900-25-103661
Chunk: 1

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-10-30
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                   
   Number                                                                                    
     99.1      Press Release dated October 29, 2025                                          
 ─────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURE

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  CERO THERAPEUTICS HOLDINGS, INC.                               
  By:                                   /s/ Chris Ehrlich        
  Name:                                 Chris Ehrlich            
  Title:                                Chief Executive Officer  

Dated: October 29, 2025